Image-guided programming deep brain stimulation improves clinical outcomes in patients with Parkinson's disease.
Journal
NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390
Informations de publication
Date de publication:
27 Jan 2024
27 Jan 2024
Historique:
received:
02
10
2023
accepted:
09
01
2024
medline:
28
1
2024
pubmed:
28
1
2024
entrez:
27
1
2024
Statut:
epublish
Résumé
Deep brain stimulation (DBS) is an effective treatment for patients with Parkinson's disease (PD). However, some patients may not respond optimally to clinical programming adjustments. Advances in DBS technology have led to more complex and time-consuming programming. Image-guided programming (IGP) could optimize and improve programming leading to better clinical outcomes in patients for whom DBS programming is not ideal due to sub-optimal response. We conducted a prospective single-center study including 31 PD patients with subthalamic nucleus (STN) DBS and suboptimal responses refractory to clinical programming. Programming settings were adjusted according to the volumetric reconstruction of the stimulation field using commercial postoperative imaging software. Clinical outcomes were assessed at baseline and at 3-month follow-up after IGP, using motor and quality of life (QoL) scales. Additionally, between these two assessment points, follow-up visits for fine-tuning amplitude intensity and medication were conducted at weeks 2, 4, 6, and 9. After IGP, twenty-six patients (83.9%) experienced motor and QoL improvements, with 25.8% feeling much better and 38.7% feeling moderately better according to the patient global impression scale. Five patients (16.1%) had no clinical or QoL changes after IGP. The MDS-UPDRS III motor scale showed a 21.9% improvement and the DBS-IS global score improved by 41.5%. IGP optimizes STN-DBS therapy for PD patients who are experiencing suboptimal clinical outcomes. These findings support using IGP as a standard tool in clinical practice, which could save programming time and improve patients' QoL.
Identifiants
pubmed: 38280901
doi: 10.1038/s41531-024-00639-9
pii: 10.1038/s41531-024-00639-9
doi:
Types de publication
Journal Article
Langues
eng
Pagination
29Informations de copyright
© 2024. The Author(s).
Références
Limousin, P. & Foltynie, T. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat. Rev. Neurol. 15, 234–242 (2019).
doi: 10.1038/s41582-019-0145-9
pubmed: 30778210
Frizon, L. A. et al. Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson’s disease. J. Neurosurg. 130, 1841–1846 (2018).
doi: 10.3171/2018.1.JNS171660
Rolston, J. D., Englot, D. J., Starr, P. A. & Larson, P. S. An unexpectedly high rate of revisions and removals in deep brain stimulation surgery: Analysis of multiple databases. Parkinsonism Relat. Disord. 33, 72–77 (2016).
doi: 10.1016/j.parkreldis.2016.09.014
pubmed: 27645504
pmcid: 5240785
Kluger, B. M., Foote, K. D., Jacobson, C. E. & Okun, M. S. Lessons learned from a large single center cohort of patients referred for DBS management. Parkinsonism Relat. Disord. 17, 236–239 (2011).
doi: 10.1016/j.parkreldis.2010.05.003
pubmed: 20627660
Koeglsperger, T., Palleis, C., Hell, F., Mehrkens, J. H. & Bötzel, K. Deep brain stimulation programming for movement disorders: Current concepts and evidence-based strategies. Front Neurol. 10, 1–20 (2019).
doi: 10.3389/fneur.2019.00410
Moro, E., Poon, Y.-Y. W., Lozano, A. M., Saint-Cyr, J. A. & Lang, A. E. Subthalamic Nucleus Stimulation Improvements in Outcome with Reprogramming. Arch. Neurol. 63, 1266 (2006).
pubmed: 16831958
Krauss, J. K. et al. Technology of deep brain stimulation: current status and future directions. Nat. Rev. Neurol. 17, 75–87 (2021).
doi: 10.1038/s41582-020-00426-z
pubmed: 33244188
Paek, S. H. et al. The clinical impact of precise electrode positioning in STN DBS on three-year outcomes. J. Neurol. Sci. 327, 25–31 (2013).
doi: 10.1016/j.jns.2013.01.037
pubmed: 23465484
Dembek, T. A. et al. Sweetspot mapping in deep brain stimulation: Strengths and limitations of current approaches. Neuromodulation 25, 877–887 (2022).
doi: 10.1111/ner.13356
pubmed: 33476474
Nguyen, T. A. K. et al. Directional stimulation of subthalamic nucleus sweet spot predicts clinical efficacy: Proof of concept. Brain Stimul. 12, 1127–1134 (2019).
doi: 10.1016/j.brs.2019.05.001
pubmed: 31130498
Sánchez-Gómez, A. et al. Utility of postoperative imaging software for deep brain stimulation targeting in patients with movement disorders. World Neurosurg. 166, e163–e176 (2022).
doi: 10.1016/j.wneu.2022.06.132
pubmed: 35787960
Waldthaler, J. et al. Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson’s disease. Brain Stimul. 14, 1109–1117 (2021).
doi: 10.1016/j.brs.2021.07.064
pubmed: 34352356
Pourfar, M. H. et al. Model-based deep brain stimulation programming for Parkinson’s disease: The GUIDE pilot study. Stereotact. Funct. Neurosurg. 93, 231–239 (2015).
doi: 10.1159/000375172
pubmed: 25998447
Pavese, N., Tai, Y. F., Yousif, N., Nandi, D. & Bain, P. G. Traditional trial and error versus neuroanatomic 3-dimensional image software-assisted deep brain stimulation programming in patients with Parkinson disease. World Neurosurg. 134, e98–e102 (2020).
doi: 10.1016/j.wneu.2019.09.106
pubmed: 31568905
Lange, F. et al. Reduced programming time and strong symptom control even in chronic course through imaging-based DBS programming. Front Neurol. 12, 1–9 (2021).
doi: 10.3389/fneur.2021.785529
Vilkhu, G. et al. Clinician vs. imaging-based subthalamic nucleus deep brain stimulation programming. Parkinsonism Relat. Disord. 106, 105241 (2023).
doi: 10.1016/j.parkreldis.2022.105241
pubmed: 36525899
Tagliati, M. & Alterman, R. L. What is deep brain stimulation “Failure” and how do we manage our own failures? Arch. Neurol. 62, 1938–1939 (2005).
doi: 10.1001/archneur.62.12.1938-b
Vitek, J. L. et al. Lead location as a determinant of motor benefit in subthalamic nucleus deep brain stimulation for Parkinson’s disease. Front Neurosci. 16, 1–11 (2022).
doi: 10.3389/fnins.2022.1010253
Okun, M. S. et al. Management of referred deep brain stimulation failures. Arch. Neurol. 62, 1250 (2005).
doi: 10.1001/archneur.62.8.noc40425
pubmed: 15956104
Farris, S. & Giroux, M. Retrospective review of factors leading to dissatisfaction with subthalamic nucleus deep brain stimulation during long-term management. Surg. Neurol. Int 4, 69 (2013).
doi: 10.4103/2152-7806.112612
pubmed: 23776755
pmcid: 3683170
Schnitzler, A. et al. Directional deep brain stimulation for Parkinson’s disease: Results of an international crossover study with randomized, double-blind primary endpoint. Neuromodulation 25, 817–828 (2021).
doi: 10.1111/ner.13407
Debove, I. et al. Deep brain stimulation: when to test directional? Mov. Disord. Clin. Pr. 10, 434–439 (2023).
doi: 10.1002/mdc3.13667
Welter, M. L. et al. Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology 82, 1352–1361 (2014).
doi: 10.1212/WNL.0000000000000315
pubmed: 24647024
pmcid: 4001189
Treu, S. et al. Deep brain stimulation: Imaging on a group level. Neuroimage 219, 117018 (2020).
doi: 10.1016/j.neuroimage.2020.117018
pubmed: 32505698
Dembek, T. A. et al. Probabilistic sweet spots predict motor outcome for deep brain stimulation in Parkinson disease. Ann. Neurol. 86, 527–538 (2019).
doi: 10.1002/ana.25567
pubmed: 31376171
Hamel, W. et al. Targeting of the subthalamic nucleus for deep brain stimulation: A survey among Parkinson disease specialists. World neurosurg. 99, 41–46 (2017).
doi: 10.1016/j.wneu.2016.11.012
pubmed: 27838430
Reinacher, P. C. et al. Automatic segmentation of the subthalamic nucleus: A viable option to support planning and visualization of patient-specific targeting in deep brain stimulation. Operat. Neurosurg. 17, 497–502 (2019).
doi: 10.1093/ons/opz015
Duffley, G. et al. Interactive mobile application for Parkinson’s disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial. Parkinsonism Relat. Disord. 109, 105346 (2023).
doi: 10.1016/j.parkreldis.2023.105346
pubmed: 36966051
Mei, J., Chang, B., Xiong, C., Jiang, M. & Niu, C. A new application of functional zonal image reconstruction in programming for Parkinson’s disease treated using subthalamic nucleus–deep brain stimulation. Front Neurol. 13, 1–6 (2022).
doi: 10.3389/fneur.2022.916658
Dayal, V. et al. Novel programming features help alleviate subthalamic nucleus stimulation-induced side effects. Mov. Disord. 35, 2261–2269 (2020).
doi: 10.1002/mds.28252
pubmed: 32979290
Hollunder, B. et al. Toward personalized medicine in connectomic deep brain stimulation. Prog. Neurobiol. 210, 102211 (2022).
doi: 10.1016/j.pneurobio.2021.102211
pubmed: 34958874
Chuang, T.-C., Tan, J.-Q. & Chen, S.-M. Comparison of intraoperative imaging guided versus microelectrode recording guided deep brain stimulation for Parkinson’s disease: a meta-analysis. Neurocirugia (Astur: Engl. Ed.). 34, 228–237 (2023).
doi: 10.1016/j.neucir.2022.09.002
pubmed: 36931932
Chaturvedi, A., Butson, C. R., Lempka, S. F., Cooper, S. E. & Mclntyre, C. C. Patient-specific models of deep brain stimulation: Influence of field model complexity on neural activation predictions. Brain Stimul. 3, 65–67 (2010).
doi: 10.1016/j.brs.2010.01.003
pubmed: 20607090
pmcid: 2895675
McIntyre, C. C., Richardson, A. G. & Grill, W. M. Modeling the excitability of mammalian nerve fibers: Influence of afterpotentials on the recovery cycle. J. Neurophysiol. 87, 995–1006 (2001).
doi: 10.1152/jn.00353.2001
Carl B. et al. Visualization of volume of tissue activated modeling in a clinical planning system for deep brain stimulation. J. Neurosurg. Sci. https://doi.org/10.23736/s0390-5616.19.04827-6 (2020).